Evidence map›Paper›PMID 25646457›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Noncanonical coproporphyrin-dependent bacterial heme biosynthesis pathway that does not use protoporphyrin.

Harry A Dailey, Svetlana Gerdes, Tamara A Dailey, Joseph S Burch, John D Phillips

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03450369 (A Phase 1B Dose Escalating Study of the Safety, Short-Term Engraftment and Action of a Singly-Applied NB01 in Adults With Moderate Acne), which is not on this map. Cited by 109 papers.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03450369 phase1completednot on this mapstarted 2018, after this paper: background citation

A Phase 1B Dose Escalating Study of the Safety, Short-Term Engraftment and Action of a Singly-Applied NB01 in Adults With Moderate Acne

TypeinterventionalSponsorNaked Biome, Inc.Ran2018 to 2018Enrolled10ConditionsAcne VulgarisArmsNB01
3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 190 citations in OpenAlex.

  1. Article
  2. Use of Porphyrin Precursors as a Novel Approach for Detection ofInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Rv3839-Rv3840 links the endogenous heme biosynthesis pathway withbioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Metabolic engineering ofProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  16. Heme and immunity: The heme oxygenase dichotomy.Journal of inorganic biochemistry · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Harry A DaileyBiomedical and Health Sciences Institute and Departments of Microbiology and Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602; hdailey@uga.edu.
Svetlana GerdesMathematics and Computer Science Division, Argonne National Laboratory, Argonne, IL 60439; and.
Tamara A DaileyBiomedical and Health Sciences Institute and Departments of Microbiology and Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602;
Joseph S BurchBiomedical and Health Sciences Institute and.
John D PhillipsDivision of Hematology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132.
University of Georgia · USArgonne National Laboratory · USHealth and Environmental Sciences Institute · USUniversity of Utah · US

Funding

Porphyrias Consortium: SupplementU54DK083909 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BALWANI, MANISHA, DESNICK, ROBERT J · 2009 to 2023
$18.5M
PORPHYRIN BIOSYNTHESIS IN NORMAL AND DISEASE STATESR01DK020503 · NIDDK · UNIVERSITY OF UTAH · PI PARKER, CHARLES J, PHILLIPS, JOHN DEARBORN · 1986 to 2012
$3.3M
Erythroid heme synthesis regulation via the ferrochelatase [2Fe-2S] clusterR01DK096051 · NIDDK · UNIVERSITY OF GEORGIA · PI DAILEY, HARRY A · 2012 to 2015
$1.5M
PORPHYRIN BIOSYNTHESIS IN NORMAL AND DISEASE STATESR37DK020503 · NIDDK · UNIVERSITY OF UTAH · PI KUSHNER, JAMES P · 1993 to 2001
$463k
Porphyrin Biosynthesis in Normal and Disease StatesR56DK020503 · NIDDK · UNIVERSITY OF UTAH · PI PHILLIPS, JOHN DEARBORN · 2013 to 2013
$149k
NIDDK NIH HHS DK020503NIDDK NIH HHS DK083909NIDDK NIH HHS DK096051NIDDK NIH HHS R01 DK020503NIDDK NIH HHS R01 DK096051NIDDK NIH HHS R37 DK020503NIDDK NIH HHS R56 DK020503NIDDK NIH HHS U54 DK083909
6 · The paper itself

Abstract

It has been generally accepted that biosynthesis of protoheme (heme) uses a common set of core metabolic intermediates that includes protoporphyrin. Herein, we show that the Actinobacteria and Firmicutes (high-GC and low-GC Gram-positive bacteria) are unable to synthesize protoporphyrin. Instead, they oxidize coproporphyrinogen to coproporphyrin, insert ferrous iron to make Fe-coproporphyrin (coproheme), and then decarboxylate coproheme to generate protoheme. This pathway is specified by three genes named hemY, hemH, and hemQ. The analysis of 982 representative prokaryotic genomes is consistent with this pathway being the most ancient heme synthesis pathway in the Eubacteria. Our results identifying a previously unknown branch of tetrapyrrole synthesis support a significant shift from current models for the evolution of bacterial heme and chlorophyll synthesis. Because some organisms that possess this coproporphyrin-dependent branch are major causes of human disease, HemQ is a novel pharmacological target of significant therapeutic relevance, particularly given high rates of antimicrobial resistance among these pathogens.

Indexed as

ActinobacteriaChromatography, High Pressure LiquidCoproporphyrinsGenome, BacterialGram-Positive BacteriaHemeProtoporphyrinsCoproporphyrinsHemeProtoporphyrinscoproporphyrinGram-positive bacteriaheme synthesisHemNHemQ

Identifiers

PMID25646457
PMCPMC4343137
OpenAlexW2014232133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.